Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

More research is needed to understand and treat morphea effectively.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Regenerative medicine may offer long-lasting relief for chronic pain and neuro-degenerative conditions.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.